Planning a MedTech Transaction: Partnering, Licensing, M&A or Going Public

This webinar focuses on the options to fund a medical device company at different stages of its life cycle – from seed financing to venture capital and exits. The discussion describes the tools and regulations to access the US capital market for MedTech innovation.

We highlight the steps an APAC-based MedTech company should take to increase its probability of success in the U.S. capital markets. The webinar also provides an overview of the trends in deal making in 2022, and how these have changed in recent years.

This webinar is part of the free webinar series “Expanding Beyond APAC” launched to discuss the strategies, challenges, and best practices of entering new markets and scaling beyond the Asia Pacific for MedTech companies.   

The webinar series is prepared together with APACMed, Asia Pacific’s regional trade association which represents manufacturers and providers of medical equipment and devices, in-vitro diagnostics, digital health; as well as local associations and other key stakeholders within the medical technology industry.   

Who should watch this webinar?

MedTech, digital health and IVD startups, and Small and Medium-sized Enterprises based in the Asia Pacific planning to expand commercially to Europe and North America.  

Meet the Speakers

Carlo Stimamiglio – Partner, Transaction Advisory, Alira Health

Carlo engages with Alira Health’s strategy consulting and M&A mandates for medical devices, capital equipment, and pharmaceutical companies in the U.S. and Europe. Prior to joining Alira Health, Carlo worked at a multi-billion Italian asset management firm and later joined an investment banking boutique, where he advised mid-market private equity firms in various international transactions. Carlo holds an MS in Finance from the University of Verona and an MBA from IE Business School.

Dan Pastore – Partner, Transaction Advisory, Alira Health

Dan has 20+ years of experience in institutional financial services in both public and private markets. He has extensive experience preparing management teams for capital raises and connecting with private market investors focused on minimally-invasive medical devices, digital health, biotech and specialty pharma.

Prior to joining Alira Health, he co-led the healthcare banking team at Silverwood Partners. He also founded a boutique consulting firm focused on private and public payer due diligence for private equity firms, providing revenue cycle management services and payer relations for healthcare services companies. Dan also held leadership business development positions at several investment research firms providing regulatory, legislative, geopolitical, quantitative and fundamental research to mutual funds and hedge funds.

Dan holds a BA in History from Boston College and a MBA from the University of Notre Dame.

More Resources

The 2023 U.S. MedTech Contract Manufacturing (CDMO) Report